Insider Transactions in Q4 2021 at Day One Biopharmaceuticals, Inc. (DAWN)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 21 2021	Canaan Xi L.P. > 10% Shareholder	SELL Other acquisition or disposition	Direct	536,000 -5.26%	-
Dec 08 2021	Canaan Xi L.P. > 10% Shareholder	SELL Other acquisition or disposition	Direct	536,000 -4.99%	-
Dec 08 2021	Takeda Pharmaceutical CO LTD > 10% Shareholder	SELL Open market or private sale	Indirect	110,338 -1.77%	$1,986,084 $18.03 P/Share
Dec 07 2021	Takeda Pharmaceutical CO LTD > 10% Shareholder	SELL Open market or private sale	Indirect	186,935 -1.47%	$3,364,830 $18.97 P/Share
Dec 06 2021	Takeda Pharmaceutical CO LTD > 10% Shareholder	SELL Open market or private sale	Indirect	97,692 -1.5%	$1,758,456 $18.05 P/Share
Dec 03 2021	Takeda Pharmaceutical CO LTD > 10% Shareholder	SELL Open market or private sale	Indirect	12,517 -0.19%	$225,306 $18.47 P/Share
Dec 01 2021	Samuel C. Blackman HEAD OF R&D	SELL Open market or private sale	Direct	10,000 -0.24%	$170,000 $17.56 P/Share
Nov 24 2021	Atlas Venture Fund Xi, L.P. > 10% Shareholder	SELL Other acquisition or disposition	Direct	801,138 -10.0%	-
Nov 24 2021	Takeda Pharmaceutical CO LTD > 10% Shareholder	BUY Other acquisition or disposition	Indirect	57,224 +0.87%	-
Oct 22 2021	Samuel C. Blackman HEAD OF R&D	BUY Bona fide gift	Indirect	1,000,000 +50.0%	-
Oct 22 2021	Samuel C. Blackman HEAD OF R&D	SELL Bona fide gift	Direct	1,000,000 -41.9%	-

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Value

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

Operation

Value

Type

Receive news related to Day One Biopharmaceuticals, Inc.